Primary study · included by 1 review

A first-in-human, prospective pilot trial of umbilical cord-derived mesenchymal stem cell eye drops therapy for patients with refractory non-Sjögren's and Sjögren's syndrome dry eye disease.

Zhang 2025 · Zhang Di, Chen Taige, Liang Qi, et al. · Stem cell research & therapy · 2025

Included by

Efficacy and safety of stem cell therapy for dry eye syndrome in Sjögren's syndrome: a systematic review and meta-analysis.
Non-Cochrane · intervention · 2026 · cited as Zhang 2025 · Table 1; References 16-20

The review does not say which of its outcomes this study informs.

1 including review in total.